Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - BRAIN SCIENTIFIC INC. | ex_121375.htm |
| EX-31.2 - EXHIBIT 31.2 - BRAIN SCIENTIFIC INC. | ex_121373.htm |
| EX-31.1 - EXHIBIT 31.1 - BRAIN SCIENTIFIC INC. | ex_121372.htm |
| 10-Q - FORM 10-Q - BRAIN SCIENTIFIC INC. | allsoft20180630b_10q.htm |
Exhibit 32.1
Certification of Principal Executive Officer
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
I, Amer Samad, Chief Executive Officer of All Soft Gels Inc., hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge, the quarterly report on Form 10-Q for the period ending June 30, 2018 of All Soft Gels Inc. (the “Form 10-Q") fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934 and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of All Soft Gels Inc.
Dated: August 14, 2018
/s/ Amer Samad
Amer Samad
Chief Executive Officer
(Principal Executive Officer)